A jury found McKesson and Cencora liable for $266 million in damages to the city of Baltimore for fueling the opioid crisis.

Susman Godfrey partner Bill Carmody said the $266 million “verdict was an important step toward helping Baltimore recover so ...

Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. Nilotinib was originally approved under the brand name Tasigna; it is currently indicated for adults and pediatric ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

McKesson (MCK) and Cencora (COR) ordered by a jury in Baltimore to pay $266M in damages to the city for their role in causing ...

A Baltimore jury found two drug distributors liable for contributing to the city's ongoing opioid crisis. The decision came ...

The city of Baltimore won $266 million in its lawsuit accusing top drug distributors McKesson and Cencora of fueling an ...

McKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...

McKesson and AmerisourceBergen were found liable in Baltimore, ordered to pay over $266 million for their role in the opioid ...

A Baltimore jury found two drug distributors liable for contributing to the city's ongoing opioid crisis. The decision came ...

Toshiba Corporation, GE Healthcare, Hyland Software Inc., Kofax Ltd, McKesson Corporation, Nextgen Healthcare Information Systems LLC, and Siemens Healthineers AG. These companies use various ...